Get started
Author

Livia Manzella

Selective Inhibition of Leukemia Cell Proliferation by BCR-ABL Antisense Oligodeoxynucleotides
1991 · Cezary Szczylik, Tomasz Skorski, et al. · Science · 339
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer?
2021 · Federica Martorana, Gianmarco Motta, et al. · Frontiers in Pharmacology · 214
PDF
The Insulin/IGF System in Colorectal Cancer Development and Resistance to Therapy
2015 · Paolo Giovanni Vigneri, Elena Tirrò, et al. · Frontiers in Oncology · 186
PDF
Positive Autoregulation of c-myb Expression Via Myb Binding Sites in the 5' Flanking Region of the Human c-myb Gene
1991 · N C Nicolaides, R Gualdi, et al. · Molecular and Cellular Biology · 128
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice
2019 · Elena Tirrò, Federica Martorana, et al. · Genes · 101
New Insights in Thyroid Cancer and p53 Family Proteins
2017 · Livia Manzella, Stefania Stella, et al. · International Journal of Molecular Sciences · 98
PDF
Altered Expression of c-IAP1, Survivin, and Smac Contributes to Chemotherapy Resistance in Thyroid Cancer Cells
2006 · Elena Tirrò, Maria Letizia Consoli, et al. · Cancer Research · 96
PDF
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia
2018 · Michele Massimino, Stefania Stella, et al. · Molecular Cancer · 63
PDF
Activation of the IGF Axis in Thyroid Cancer: Implications for Tumorigenesis and Treatment
2019 · Livia Manzella, Michele Massimino, et al. · International Journal of Molecular Sciences · 58
PDF
Suppression of Survivin Induced by a BCR-ABL/JAK2/STAT3 Pathway Sensitizes Imatinib-Resistant CML Cells to Different Cytotoxic Drugs
2013 · Stefania Stella, Elena Tirrò, et al. · Molecular Cancer Therapeutics · 56
Activation of the S100A7/RAGE Pathway by IGF-1 Contributes to Angiogenesis in Breast Cancer
2021 · Maria Grazia Muoio, Marianna Talia, et al. · Cancers · 49
PDF
PI3K inhibition in breast cancer: Identifying and overcoming different flavors of resistance
2021 · Silvia Rita Vitale, Federica Martorana, et al. · Critical Reviews in Oncology/Hematology · 47
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma
2021 · Elena Tirrò, Michele Massimino, et al. · Frontiers in Oncology · 44
PDF
IRF5 promotes the proliferation of human thyroid cancer cells
2012 · Michele Massimino, Paolo Vigneri, et al. · Molecular Cancer · 39
PDF
Microenvironmental Determinants of Breast Cancer Metastasis: Focus on the Crucial Interplay Between Estrogen and Insulin/Insulin-Like Growth Factor Signaling
2020 · Veronica Vella, Ernestina Marianna De Francesco, et al. · Frontiers in Cell and Developmental Biology · 36
PDF
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives
2020 · MICHELE MASSIMINO, STEFANIA STELLA, et al. · Anticancer Research · 36
PDF
Roles of Interferon Regulatory Factors in Chronic Myeloid Leukemia
2016 · Livia Manzella, Elena Tirrò, et al. · Current Cancer Drug Targets · 36
Long-acting insulin analogs and cancer
2018 · L. Sciacca, V. Vella, et al. · Nutrition Metabolism and Cardiovascular Diseases · 35
High BCR–ABL/GUSIS Levels at Diagnosis of Chronic Phase CML Are Associated with Unfavorable Responses to Standard-Dose Imatinib
2017 · Paolo Vigneri, Fabio Stagno, et al. · Clinical Cancer Research · 33
BCR‐ABL residues interacting with ponatinib are critical to preserve the tumorigenic potential of the oncoprotein
2013 · Pietro Buffa, Chiara Romano, et al. · The FASEB Journal · 33
PDF
A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients With Diffuse Gliomas: Diagnostic and Therapeutic Applications
2022 · Elena Tirrò, Michele Massimino, et al. · Frontiers in Oncology · 32
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53
2019 · Elena Tirrò, Michele Massimino, et al. · Frontiers in Oncology · 31
PDF
Opportunities and Challenges of Liquid Biopsy in Thyroid Cancer
2021 · Chiara Romano, Federica Martorana, et al. · International Journal of Molecular Sciences · 30
PDF
IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation
2014 · Michele Massimino, Maria Letizia Consoli, et al. · Carcinogenesis · 28
Biomarkers and Prognostic Factors for Malignant Pleural Mesothelioma
2015 · Paolo Vigneri, Federica Martorana, et al. · Future Oncology · 26
Works count: 111
Citation count: 2,345
H-index: 25
I10-index: 47
Year
Topic
Type